Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups
Oleg Volkov, Svetlana Borozdenkova, Alexander Gray
doi: https://doi.org/10.1101/2022.11.22.22282637
Oleg Volkov
1Xitific LTD, London, UK
Svetlana Borozdenkova
1Xitific LTD, London, UK
Alexander Gray
2IDEAPharma, Milton Keynes, UK
Data Availability
All data used for the paper are publically available online.
Posted November 25, 2022.
Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups
Oleg Volkov, Svetlana Borozdenkova, Alexander Gray
medRxiv 2022.11.22.22282637; doi: https://doi.org/10.1101/2022.11.22.22282637
Subject Area
Subject Areas
- Addiction Medicine (321)
- Allergy and Immunology (623)
- Anesthesia (162)
- Cardiovascular Medicine (2334)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11692)
- Forensic Medicine (10)
- Gastroenterology (692)
- Genetic and Genomic Medicine (3675)
- Geriatric Medicine (345)
- Health Economics (630)
- Health Informatics (2359)
- Health Policy (924)
- Hematology (339)
- HIV/AIDS (770)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (395)
- Neurology (3429)
- Nursing (194)
- Nutrition (519)
- Oncology (1798)
- Ophthalmology (531)
- Orthopedics (215)
- Otolaryngology (285)
- Pain Medicine (229)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1020)
- Primary Care Research (415)
- Public and Global Health (6081)
- Radiology and Imaging (1253)
- Respiratory Medicine (820)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)